Editor's PickMarket News

NA Proactive news snapshot: Marble Financial, PlantX Life, Altiplano Metals, Genprex, The Parent Company UPDATE …

Marble Financial Inc (CSE:MRBL) (OTCMKTS:MRBF) (FRA:2V0) said it has closed its acquisition of Canadian fintech company Inverite Verification Inc, which provides real-time access to financial data and insights. Inverite’s AI-based technology includes connectivity to 286 access points from financial institutions, and its Risk Score model is trained from millions of banking verification requests and loan behaviours. Vancouver-based Marble told investors that Inverite’s data aggregator combined with Marble’s personal finance platform MyMarble will be “transformative” for the firm’s insights and recommendation engine by creating a faster, more cost-effective system. PlantX Life Inc (CSE:VEGA) (OTCQB:PLXTF) (FRA:WNT1) said it achieved record monthly gross revenue of C$1,565,982 in March 2021, a 15.6% increase from February and a 43.7% increase from January of this year. PlantX Life noted that it continues to experience month-over-month revenue gains and is confident in its capabilities to remain on a growth trajectory for the rest of the year. “The company’s progress is a manifestation of its results-driven strategy to capitalize on high-growth verticals, create strategic partnerships and expand globally,” PlantX Life CEO Julia Frank said in a statement. “PlantX continues to add value as a leader in the plant-based industry.” Altiplano Metals Inc (CVE:APN) said it has reached 45 meters (m) of the expected 80m of required development length at the Hugo Decline, part of the underground mining activity at its Farellon Copper-Gold (Cu-Au) mine located near La Serena, Chile. The company began the extension of the Hugo Decline in March to access a 369m level access point. Intersection of that level is expected in late April or early May, the company said. The new access point will provide two additional development headings to the NW and SW directions, which the company believes will allow for improved efficiency and ultimately increased capacity. Genprex Inc (NASDAQ:GNPX) said its collaborators have presented positive preclinical data for the combination of REQORSA, the company’s proprietary TUSC2 immunogene therapy, in combination with chemotherapy and immunotherapies for the treatment of non-small cell lung cancer (NSCLC). These data were presented in two presentations at the 2021 American Association of Cancer Research (AACR) annual meeting, the company said. The TUSC2 gene is a tumor suppressor gene and is the active agent in REQORSA. “We are pleased to have these positive data that provide further support for the therapeutic potential of REQORSA in combination with immunotherapies and targeted therapies in NSCLC presented before an audience of the world’s leading cancer researchers,” Genprex CEO Rodney Varner said in a statement. The Parent Company Holding Corp (NEO:GRAM.U) (OTCQX:GRAMF) (OTCPINK:GRMWF) said that Shawn ‘JAY-Z’ Carter and his cannabis brand, MONOGRAM, which is part of The Parent Company house of brands, has launched the first installment of a three-part advertising campaign that reimagines the iconic photos of renowned mid-century American photographer Slim Aarons through a contemporary lens. The company said the current campaign will be shot by photographer Hype Williams, known for capturing some of the most striking images of modern hip hop and culture, and will depict what the ‘good life’ looks like today, which includes cannabis as part of that lifestyle. Nextleaf Solutions Ltd (CSE:OILS) (OTCQB:OILFF) (FRA:LOMA) said it has received an amendment to its cannabis processing license allowing it to sell extracts, edibles and topical products to distributors and retailers across Canada. Vancouver-based Nextleaf said the amendment – granted to its subsidiary Nextleaf Labs – will allow it to offer value-added services for a “more seamless” path to market. The amendment also gives Nextleaf more flexibility to potentially launch its own in-house brand, the company told investors. Hillcrest Energy Technologies Ltd (CSE:HEAT) (OTCMKTS:HLRTF) (FRA:7HI.F) has announced the closing of a $5 million equity facility agreement with Mercer Street Global Opportunity Fund LLC to execute against internal IP development initiatives and use as working capital. Hillcrest said it has received in escrow a first tranche of C$ $2,240,000. The Vancouver, British Columbia-based firm has the right, but not the obligation, to request further tranches under the investment agreement on meeting certain conditions. The funds drawn will be converted into shares in Hillcrest. “I am delighted to partner with Mercer Street. This funding, combined with monthly production revenues, creates a strong financial foundation that not only meets our anticipated commitments through the upcoming fiscal year; it also expands our ability to pursue new development partnership opportunities and execute against internal IP development initiatives,” Hillcrest CEO Don Currie said in a statement. American Battery Metals Corporation (OTCQB:ABML) said it has entered into a common stock purchase agreement with an institutional investor for up to $75 million worth of shares issuable over the next 24 months. The company, which is in the process of changing its name to American Battery Technology Company, noted that the institutional investor is an existing shareholder who has invested in fixed-priced equity over the past year. American Battery Metals said the structure of the purchase agreement is very similar to a commonly employed At-The-Market (ATM) structure used by many NASDAQ and NYSE-listed companies to access capital at or near current share prices.  Fury Gold Mines Limited (TSE:FURY) (NYSEAMERICAN:FURY) (FRA:AUN1) said it has identified two “compelling” target areas on the western limit of its high-grade Eau Claire project, in Quebec that may “significantly expand” the deposit. These targets are located below an area called the 850 zone and were developed through an increased understanding of the structural and lithological controls on mineralization within the deposit, said the company. Primarily using litho-geochemistry data, Fury’s technical team was able to define individual rock packages and their relative position within the anticline, which is the main structural control on the Eau Claire deposit.   INDVR Brands Inc (CSE:IDVR) (OTCMKTS:CAAOF) (FRA:3YX) announced it has signed a Letter of Intent (LOI) with BevCanna Enterprises Inc (CSE:BEV) (QTCQB:BVNNF) (FRA:7BC), in which BevCanna will produce and distribute certain HONU THC-infused edible products to retail locations across Canada. INDVR said the partnership marks the company’s first move into the Canadian cannabis market, as well as its first international expansion.  “With the THC infused product segment making up a growing percentage of the cannabis consumed in Canada, now is the ideal time to introduce our HONU brand into an edibles market estimated at approximately $1.6 billion annually,” INDVR Brands CEO Joshua Mann said in a statement.   Aurania Resources Ltd (CVE:ARU) (OTCMKTS:AUIAF) (FRA:20Q) told investors that the Tiria-Shimpia silver-zinc zone at its flagship Lost Cities – Cutucu project in Ecuador was “shaping up” to be the company’s first discovery as it reported on first channel rock-chip sampling from the area. Seven mineralized layers have been identified, one of which is 50 metres (m) thick, at Tiria-Shimpia, which is a target over 15km long. Highlight sampling results include intensely mineralized layers within dolomite, which returned grades of 2m at 12 grams per ton (g/t) silver and 3.9% zinc and 0.8m of 26 g/t silver and 6.4% zinc. Another area saw two-channel samples spaced 500m apart along a length of 1km carried out, that returned grades of 4m at 21 g/t silver and 9.3% zinc, and 1m at 8 g/t silver and 4.8% zinc. Alternus Energy Group PLC (NOTC:ALT), the fast-growing pan-European independent power producer, announced the recent issuance of €9 million convertible notes lead by AVG Group Sarl, a Luxembourg-based asset manager that specializes in scaling Nordic environmental, social and corporate governance (NSG), and technology. Alternus said AVG provided €8 million of the total investment, with the remainder being provided by private individuals. “We are delighted to have AVG as a new financing partner and look forward to working with them going forward as we continue to grow Alternus over the next few years in our continuing mission to become one of the largest pan-European solar operators by the end of the decade,” Alternus Energy CEO Vincent Browne said in a statement. QC Copper and Gold Inc.(CVE:QCCU) (OTCMKTS:QCCUF) has reported assays from the first three diamond drill holes of a planned 75, at its Opemiska project’s Springer mine in Quebec, ahead of a near surface, pit-constrained resource estimate earmarked for later this year.  The project covers 12,782 hectares and covers the past producing Springer, Perry, Robitaille and Cooke mines, owned and operated by Falconbridge, and as of April 10, this year, 11,460 metres (m) of drilling had been achieved with 56 holes either completed or in progress. “The observed mineralization in this program’s drill core is very consistent with our expectations, and with assays now starting to arrive, our expectation is for batch results to arrive once or twice a week until the end of program,” said Charles Beaudry, vice-president (VP) of exploration and director at the company. Aurelius Minerals Inc (CVE:AUL) (OTCQB:AURQF) (FRA:1GA) said that new drill results from its Aureus East gold project in Nova Scotia have encountered “multiple” high-grade gold horizons. The junior company said that all three underground drill holes from the Aureus project intersected the expanding Gold Zone 9 on the property. Highlights of the results included 3 metres (m) at 17.4 grams per ton (g/t) gold, including 1m at 43.3 g/t gold, 2.7m at 15.1 g/t gold, including 1m at 39.7 g/t gold and 5.7m at 9.4 g/t gold, including 1.7m at 28.8 g/t gold. ImagineAR Inc (CSE:IP) (OTCQB:IPNFF) (FRA:GMS1) and blockchain fintech company Liquid Avatar Technologies Inc (CSE:LQID) (OTCPINK:TRWRF) (FRA:4T51), together with DreamView Studios, announced that Oasis Digital Studios has partnered with US Grammy nominated rapper Jeezy to create an animated non-fungible token (NFT) of his Snowman logo. The NFT will be available beginning in late April, and a pre-sale waiting list is available for prospective purchasers and collectors on the Oasis website as of today. Oasis said the Snowman NFT is the first of many offerings to come and that Jeezy is taking NFTs to a new level by embracing 3D and augmented reality (AR) technology in the production of his art. Neo Lithium Corp (CVE:NLC) (OTCQX:NTTHF) (FRA:NE2) said it has hired Golder Associates Ltd, as well as the Argentinean National University of San Martin (UNSAM), to assist with the Environmental, Social and Governance (ESG) program as part of the Definitive Feasibility Study (DFS) in preparation for the future construction and operation of Neo Lithium’s 3Q Lithium Project in Argentina. As part of the ESG protocols for the 3Q project, Golder will estimate the project’s carbon footprint and benchmark the carbon intensity and other key ESG metrics against similar projects. Cardiol Therapeutics Inc. (TSE:CRDL) (OTCQX:CRTPF) (FRA:CT9) announced topline results from its Phase I clinical trial of CardiolRx, its pharmaceutically-produced oral cannabidiol formulation. The biotechnology company said the results from the single and multiple ascending dose trial indicate that the drug was safe and well-tolerated at all dose levels, with no serious side effects reported. As well, pharmacokinetic studies determined that blood levels of the drug tended to rise hand-in-hand with an increasing dose.  Kintara Therapeutics Inc (NASDAQ:KTRA) has announced interim data from two Phase 2 clinical trials of its lead compound, VAL-083 for glioblastoma multiforme (GBM), which continue to demonstrate its potential as a “game-changing treatment option”. The data were presented in two posters at the 2021 American Association for Cancer Research (AACR) annual meeting, which is taking place virtually from April 10 to April 15, 2021. The first poster concerned the two patient groups receiving VAL-083 in an open-label, Phase 2 study in recurrent and adjuvant (after initial treatment) unmethylated GBM settings being conducted at the MD Anderson Cancer Center in Texas. The second poster updated on the open-label, Phase 2 study of VAL-083 as a first-line treatment in newly-diagnosed, unmethylated GBM patients being conducted at Sun Yat-sen University Cancer Center in China. TraceSafe Inc (CSE:TSF), a global leader in wearable safety tech, has announced that it is now a member of the Future Borders Coalition. The coalition helps to advance the efficiency and security of the Canada-US border, which has been closed for non-essential travel for over one year due to the coronavirus (COVID-19) pandemic. TraceSafe said that, given its unique experience using technology to enhance safety and efficiency for governments and border crossings around the world, the new partnership will be a strong foundation for the border’s eventual re-opening. Essex Minerals Inc (CVE:ESX) (OTCQB:ESXMF) (FRA:EWX1) has elected to be Zola Minerals Inc’s exclusive financing partner for a new streaming and royalty company, with a focus on renewable energy. Essex said the new company will be funded separately with the founding shares in the new venture to be distributed pro-rata to Essex shareholders. A meeting of shareholders has been called for June 10, 2021, to approve the capital distribution. The company noted that Zola has secured exclusive access to a pipeline of long-life renewable energy streams and is in advanced negotiation on additional streams in the renewable energy and metals sectors. AgraFlora Organics International Inc (CSE: AGRA) (FRA:PU31) (OTCPINK:AGFAF) announced that its German pharmaceutical wholesale subsidiary, Farmako GmbH, has begun supplying its proprietary THC Testkits to Stadapharm GmbH.  The THC Testkit was developed and produced by Farmako in-house as a tool for pharmacists to detect THC and identify medical cannabis flowers and extracts easily, quickly and at low cost, the company said. Stadapharm, which is responsible for the specialty pharmaceuticals business within the German STADA Group, is expected to enter the medical cannabis market in the second quarter of 2021 Benchmark Metals Inc (CVE:BNCH) (OTCQB:CYRTF) (FRA:87CA) has released more drill results from its flagship Lawyers project in British Columbia, which it said underscore the asset’s world-class mining potential. The results come from new holes from the northern portion of the Cliff Creek deposit and show “exceptional continuity of high grade and bulk-tonnage mineralization from surface to over 500 metres (m) vertical depth”, the junior explorer noted. Results from below the already modelled pit included 4.82 metres (m) of 11.58 grams per ton (g/t) gold and 711.85 g/t silver from a depth of 491m. Another hole hit a zone of high-grade mineralization continuing over 150 metres along strike. returning from surface 54.72 m of 2.86 g/t gold and 152.18 g/t silver. Green Battery Minerals Inc (CVE:GEM) (OTCMKTS:GBMIF) (FRA:BK2P) said it has received conditional approval and will now apply to the TSX Venture Exchange for approval to close a private placement for proceeds of $2,113,000. Green Battery said a total of 10,565,000 units have been subscribed at $0.20 each, consisting of one common share and one warrant exercisable for two years at $0.50 cents apiece. The company said the proceeds will be used for working capital and continued exploration on the company’s properties. Australis Capital Inc (CSE:AUSA) (OTC:AUSAF) (FRA:AC4) has appointed Jason Dyck, director of the Cardiovascular Research Centre at the University of Alberta, as its new chief science officer and chairman of its scientific advisory board, the company announced. Dyck has a wealth of experience leading cannabis-related medical research and has deep connections and high standing in the industry, the company said. He previously led the research and science team at Aurora Cannabis Inc (NYSE:ACB) (TSE:ACB) (FRA:21P1) in its formative years, playing a significant role in helping it become the medical cannabis industry leader that it is today, Australis said. The company’s appointments strategy is to leverage the roots of its management team in medical cannabis, while developing offerings and partnerships aimed at the medical and wellness markets.  Else Nutrition Holdings Inc (CVE:BABY) (OTCQX:BABYF) (FRA:0YL) has announced the addition of two world-class experts – Hania Szajewska and Carina Venter – to its Scientific Advisory Board.  The company said that Szajewska is a professor and chair of the Department of Pediatrics at the Medical University of Warsaw. She will lead Else’s clinical studies in Europe. Its second appointee Dr Venter is currently an associate professor of pediatrics, section of Allergy/Immunology at the Children’s Hospital Colorado and the University of Colorado Denver, where she is conducting research in allergy prevention and working with children with food allergies. She will lead Else’s hypoallergenicity studies in the US. Aion Therapeutic Inc. (CSE:AION) said that it has retained KCSA Strategic Communications (KCSA), a leading New York City-based communications firm. KCSA will work with Aion’s management to create a comprehensive, strategic communications program to lead the company’s public and investor relations programs.  “As we enter the next phase of growth for the Company, we have retained KCSA to help broaden our exposure to the investment community and to represent us in the media,” commented Graham Simmonds, executive vice chair and CEO of Aion Therapeutic. “Our Company is at a very exciting stage and we look forward to communicating how our patented approach of utilizing psilocybin and other mushroom compounds in combination with cannabinoids to treat serious medical conditions to the global medical community.” For its services supporting the company’s public relations and investor relations efforts, KCSA will receive US$15,000 per month. The term of the engagement will be initially six months and then ongoing on a month-to-month basis. The company has the right to terminate the relationship with KCSA on 90 days’ notice. Thoughtful Brands, Inc.(CSE:TBI) (FRA:1WZ1) (OTCQB:PEMTF), an eCommerce technology company that researches, develops, markets, and distributes natural health products through various brands in North America and Europe, has said it intends to consolidate its issued and outstanding common shares at a ratio of ten pre-consolidated shares to one post-consolidation share. The company currently has 389,274,701 shares issued and outstanding. Following the Consolidation, there will be approximately 38,927,470 Scares issued and outstanding. No fractional shares will be issued and any fractions of a share will be rounded down to the nearest whole number of shares. The exercise or conversion price and the number of shares issuable under any of the company’s outstanding convertible securities will be proportionately adjusted upon consolidation. GlobeX Data Ltd. (OTCQB:SWISF) (CSE:SWIS) (FRA:GDT) announced that, on April 9, 2021, subject to any necessary regulatory approvals, it granted incentive stock options to purchase in aggregate 4,820,000 shares of its common stock. Of such options, 4,800,000 were granted to a group of four officers and directors of the company and 20,000 were granted to an employee of the accounting firm of the company and the company’s corporate secretary. All options were granted under the company’s stock option plan and are all exercisable for a period of five years at a price of C$0.50 per share. They are subject to the company’s customary vesting policy. Else Nutrition Holdings Inc. (CVE:BABY) (OTCQX:BABYF) (FRA:0YL) said it has issued 37,632 common shares of the company to Agora Internet Relations Corp., an arm’s length consultant, in full satisfaction of online advertising services valued at $67,800 (including applicable taxes), which were rendered to it under a shares-for-services agreement. The share issuances were payable in five equal installments using a deemed price per share equal to the company’s closing market price on the TSX Venture Exchange on March 11, 2020, June 11, 2002, September 11, 2020, December 11, 2020 and March 11, 2021. Accordingly, in settlement of the entire amount owed under the agreement: (i) 15,950 shares were issued at $0.80 per share; (ii) 8,370 shares were issued at $1.62 per share; (iii) 5,098 shares were issued at $2.66 per share; (iv) 3,283 shares were issued at $4.13 per share; and (v) 3,930 shares were issued at $3.45 per share. Helix BioPharma Corp. (TSX:HBP) (FRA:HBP) said it has received conditional approval from the Toronto Stock Exchange (TSX) to extend the exercise period of a total of 2,837,000 outstanding common share purchase warrants, all of which are held by arm’s length parties. The warrants were issued under a private placement of the company completed on April 27, 2016 and represent approximately 2.0% of the company’s issued and outstanding common shares. Each warrant currently entitles the holder to purchase one common share of the company at an exercise price of $1.98 at any time until April 27, 2021. Subject to TSX approval, the expiry date of the warrants will be extended by two years to April 26, 2023. The exercise price of the Warrants will remain unchanged at $1.98. If approved by the TSX, the effective date of the amendment will be April 27, 2021. One World Lithium Inc. (OTCMKTS:OWRDF) (CSE:OWLI) (CNSX:OWLI.CN) has said that with that effect from April 12, 2021, it will amend the terms of an aggregate of 4,584,390 outstanding common share purchase warrants previously issued by the company. It noted that 1,752,257 of these warrants, currently exercisable at a price of $0.20 until April 10, 2021, will see the exercise price reduced to $0.15 and the term of the warrants extended by an additional twelve months until April 10, 2022; 995,668 of the warrants, currently exercisable at a price of $0.20 until June 04, 2021, will see the exercise price reduced to $0.15 and the term extended by an additional twelve months until June 04, 2022; and 1,836,465 of the warrants, currently exercisable at a price of $0.20 until July 08, 2021, will see the exercise price reduced to $0.15 and the term extended by an additional twelve months until July 08, 2022.  All other warrant terms remain the same. NEXE Innovations Inc (CVE:NEXE) (OTCQX:NEXNF) has said that Ash Guglani, its president, will present at the Global Chinese Financial Forum (GCFF) on Thursday, April 15, 2021, at 11.40am PST (12.40pm MT). GCFF is the largest conference that caters to the Chinese investment community in North America. Hosted by NAI Interactive Ltd., the bilingual online event will feature public and private company investment opportunities and will be broadcast in English and Mandarin Chinese. The conference is virtual, with no cost or restrictions to attend, and investors can register for it via the following link: https://gcff-apr-2021.eventbrite.ca/?aff=NAI500EventEng. An archived link to the presentation will be made available approximately one week after the live event under the investors section of NEXE’s website at: https://nexeinnovations.com/investors/. PyroGenesis Canada Inc. (TSX:PYR) (NASDAQ:PYR) (FRA:8PY) has announced that it will be presenting at the virtual Planet MicroCap Showcase on Wednesday, April 21, 2021, at 10.00am Eastern Time. It said that P. Peter Pascali, the company’s CEO and chair will be hosting the presentation and answering questions from investors. To access the live webcast: https://www.webcaster4.com/Webcast/Page/2059/40584. To book 1on1 investor meetings with PyroGenesis, and to watch PyroGenesis’ presentation, investors can register for the virtual event here: https://planetmicrocapshowcase.com/signup. For those that are unable to attend the live presentation, the webcast replay will be available directly on the conference event platform via the following link under the tab “Agenda”: https://planetmicrocapshowcase.com/agenda. Medexus Pharmaceuticals Inc. (CVE:MDP) (OTCQX:MEDXF) (FRA:P731), has announced that Ken d’Entremont, its CEO, and Roland Boivin, its CFO, will be participating in the Bloom Burton & Co. Healthcare Investor Conference on Tuesday, April 20, 2021, at 11.00am ET. To register for the virtual conference, investors can use the following link: https://www.bloomburton.com/conference/. Medexus said it will also be participating in several one-on-one investor meetings on Wednesday, April 21, 2021, at the Stifel 2021 Canada Cross Sector Insight Conference. Investors should contact their Stifel representatives for more details. Virtual Investor Conferences, the leading proprietary investor conference series, has announced the agenda for its upcoming Technology Virtual Investor Conference. The program opens at 9.00am on Thursday, April 15, 2021, with the first live webcast at 9.30am ET. Individual investors, institutional investors, advisors and analysts are invited to attend and can register via the following link: https://bit.ly/3wMVnht. For more information about the program and to view a complete calendar of Virtual Investor Conferences, investors can visit: www.virtualinvestorconferences.com. A real-time solution for investor engagement, Virtual Investor Conferences is part of OTC Market Group Inc.’s (OTCQX:OTCM) suite of investor relations services specifically designed for more efficient Investor Access. Replicating the look and feel of on-site investor conferences, Virtual Investor Conferences combine leading-edge conferencing and investor communications capabilities with a comprehensive global investor audience network.

Leave a Reply

Your email address will not be published. Required fields are marked *